EBErin L. Bredeweg

Erin L. Bredeweg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Erin L. Bredeweg has a total of 127 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synthetic Soil Aggregates: Bioprinted Habitats for High-Throughput Microbial Metaphenomics

    by Darian Smercina, Neerja Zambare, Kirsten Hofmockel, Natalie Sadler, Erin L. Bredeweg, Carrie Nicora, Lye Meng Markillie, Jayde Aufrecht

    The dynamics of microbial processes are difficult to study in natural soil, owing to the small spatial scales on which microorganisms operate and to the opacity and chemical complexity of the soil habitat. To circumvent these challenges, we have created a 3D-bioprinted habitat that mimics aspects of natural soil aggregates while providing a chemically defined and translucent alternative culturing method for soil microorganisms. Our Synthetic Soil Aggregates (SSAs) retain the porosity, permeability, and patchy resource distribution of natural soil aggregates—parameters that are expected to influence emergent microbial community interactions. We demonstrate the printability and viability of several different microorganisms within SSAs and show how the SSAs can be integrated into a multi-omics workflow for single SSA resolution genomics, metabolomics, proteomics, lipidomics, and biogeochemical assays. We study the impact of the structured habitat on the distribution of a model co-culture microbial community and find that it is significantly different from the spatial organization of the same community in liquid culture, indicating a potential for SSAs to reproduce naturally occurring emergent community phenotypes. The SSAs have the potential as a tool to help researchers quantify microbial scale processes in situ and achieve high-resolution data from the interplay between environmental properties and microbial ecology.


  • Optimizing Oil Production in Oleaginous Yeast by Cell-Wide Measurements and Genome-Based Models (Final Report)

    by Gregory N Stephanopoulos, James C. Liao, Jens Christian Nielsen, Scott E. Baker, Andreas E. Vasdekis, Adrian A. Fay, Kangjian Qiao, Andrew Michael Silverman, Nian (Steven) Liu, Peng Xu, et al.

    The work funded under this DOE genomics grant focused on characterizing, modifying and developing genetic engineering tools for the then very promising but under-characterized oleaginous yeast Yarrowia lipolytica. To‐date, all biodiesel production facilities rely on vegetable oils and animal fats as feedstocks, which are very limited. Nature, on the other hand, is very well equipped for making carbohydrates, which are very plentiful throughout the world and rather well distributed in various forms. While numerous (biochemical and thermochemical) technologies exist presently for carbohydrate conversion to alcohols, there is none available for the cost‐efficient production of lipids from carbohydrate feedstocks. Such a technology would have wide‐ranging implications in land use, renewable resource utilization and production of transportation fuels with minimal carbon footprint. The global research objectives of this award were to develop tools for cell‐wide measurement of metabolites and lipids that, along with transcriptional data, will allow the construction of genome‐scale metabolic models, as well as models of transcriptional regulation, that will guide the further metabolic engineering of Yarrowia lipolytica. To achieve these goals, a very strong international and diverse team consisting of research groups at MIT, UCLA, PNNL and Chalmers University was put together, whose specific goals, achievements and breakthroughs are summarized below: MIT, the lead institution for this award, focused on the characterization and further engineering of the two over-producing Yarrowia strains that had already been engineered on which future yield, title and productivity enhancements were based. These were the overproducing Hr3/D9 strain expressing delta-9 stearoyl-CoA desaturase (SCD), and the ACC-DGA strain, which expressed the genes Acetyl-CoA carboxylase (ACC1), and Diacylglyceride acyl-transferase (DGA1). Once majority of lipogenic improvements were achieved by these prior efforts, the focus turned on several genetic engineering, fermentation and modeling strategies to achieve further gains in figures of merit of yield, productivity and titer, including: Assuring the lipogenesis pathway has no limitations in its requirement of reducing equivalents (NADPH); systematically identifying and investigating the lipogenic effect of a promising panel of 44 different lipogenesis-related genes of Yarrowia in 7 different categories; exploring the possibility of loss of lipids via catabolic processes; investigating how to mitigate the effects of the unique nitrogen starvation conditions required, which leave the cells in an unfavorable physiological state; establishing a mathematical model to guide identification and rewire of the central carbon metabolism towards optimization of process yield of lipids; and, observing the behavior of our strains when fed with acetate, a dilute mixture of organic volatile fatty acids (VFAs) and dilute biomass hydrolysates (which include xylose) With starting Yarrowia Hr3/D9 and ACC1/DGA1 strains already having a maximum productivity of 0.253g/L/h (during the lipid accumulation phase of the fermentation), yield of about 0.2 grams of oil per gram of glucose consumed, titer of 55-75 g/Lt in 72 hrs, and lipid content of 62% dry cell weight, our best strain grown in 3 liter bioreactor was able to reach a titer of 98 g/L, productivity of 1.2 g/L/h and a process yield of 0.269 g/g from a single fed‐batch fermentation. UCLA worked to construct dynamic models of Yarrowia lipolytica and use them to identify gene targets for improving lipid production. No such models were available at the genome scale when this project started. The particularly attractive approach of Ensemble Modeling (EM), starts with a cell-wide metabolic reconstruction of the target species, and generates an ensemble of dynamic models reaching the same steady state characterized by 13C flux measurements, provided by the MIT team. The availability of such dynamic models is invaluable in identifying targets for speeding up the lipid production process, as suggested by numerous test cases using EM for productivity improvement. The following was achieved: Reconstruction of a cell-wide description of Yarrowia metabolism using literature information (in collaboration with the Chalmers team). Building of an ensemble of dynamic, kinetic models following the EM protocol, given a cell-wide reconstruction of the ACC1+DGA1Yarrowia strain metabolism using 13C flux measurements. In-silico overexpression (up to 2-fold) and knockdown (down to 50%) of every single enzyme using the ensemble of dynamic models (Ensemble Modeling for Robustness Analysis) and identified potential gene targets for productivity improvement. Discovery of reference fluxes for acetic acid metabolism in Yarrowia and predicted potential gene targets to optimize lipid yield with Ensemble Modeling (EM). The efforts from the research group at Chalmers University of Technology primarily focused on the following topics: Genome-scale model reconstruction and method development; elucidation of the regulation underlying lipid accumulation in Y. lipolytica; establishing a Y. lipolytica amenable and suitable for further genetic engineering, and to investigate the effects of increased lipid production in yeast S. cerevisiae as a base model as well analyze transcriptional changes on strains accumulating increased levels of triacylglycerides (TAG) PNNL’s initial work was focused on generating a multi-omic and microscopy datasets for the characterization of lipogenesis in Y. lipolytica. Concurrent with the multi-omic studies, PNNL developed a number of molecular genetic research tools for Yarrowia that were disseminated to the other participants in the project. These included: A NHEJ deficient mutant that greatly increased the efficiency of targeted transformation; the “Yarrowia Cell Atlas”, consisting of various...

  • Open Access

    Remodeling of the Histoplasma Capsulatum Membrane Induced by Monoclonal Antibodies

    by Meagan C. Burnet, Daniel Zamith-Miranda, Heino M. Heyman, Karl K. Weitz, Erin L. Bredeweg, Joshua D. Nosanchuk, Ernesto S. Nakayasu

    Antibodies play a central role in host immunity by directly inactivating or recognizing an invading pathogen to enhance different immune responses to combat the invader. However, the cellular responses of pathogens to the presence of antibodies are not well-characterized. Here, we used different mass spectrometry techniques to study the cellular responses of the pathogenic fungus Histoplasma capsulatum to monoclonal antibodies (mAb) against HSP60, the surface protein involved in infection. A proteomic analysis of H. capsulatum yeast cells revealed that mAb binding regulates a variety of metabolic and signaling pathways, including fatty acid metabolism, sterol metabolism, MAPK signaling and ubiquitin-mediated proteolysis. The regulation of the fatty acid metabolism was accompanied by increases in the level of polyunsaturated fatty acids, which further augmented the degree of unsaturated lipids in H. capsulatum’s membranes and energy storage lipids, such as triacylglycerols, phosphatidylcholines, phosphatidylethanolamines and phosphatidylinositols. MAb treatment also regulated sterol metabolism by increasing the levels of cholesterol and ergosterol in the cells. We also showed that global changes in the lipid profiles resulted in an increased susceptibility of H. capsulatum to the ergosterol-targeting drug amphotericin B. Overall, our data showed that mAb induction of global changes in the composition of H. capsulatum membranes can potentially impact antifungal treatment during histoplasmosis.


  • Open Access

    A Histoplasma capsulatum lipid metabolic map identifies antifungal targets

    by Daniel Zamith-Miranda, Heino M. Heyman, Meagan C. Burnet, Sneha P. Couvillion, Xueyun Zheng, Nathalie Munoz, William C. Nelson, Jennifer E. Kyle, Erika M. Zink, Karl K. Weitz, et al.

    Lipids play a fundamental role in fungal cell biology, being essential cell membrane components and major targets of antifungal drugs. A deeper knowledge of lipid metabolism is key for developing new drugs and a better understanding of fungal pathogenesis. Here we built a comprehensive map of the Histoplasma capsulatum lipid metabolic pathway by incorporating proteomic and lipidomic analyses. We performed genetic complementation and overexpression of H. capsulatum genes in Saccharomyces cerevisiae to validate reactions identified in the map and to determine enzymes responsible for catalyzing orphan reactions. The map led to the identification of both the fatty acid desaturation and the sphingolipid biosynthesis pathways as targets for drug development. We found that the sphingolipid biosynthesis inhibitor myriocin, the fatty acid desaturase inhibitor thiocarlide and the fatty acid analog 10-thiastearic acid inhibit H. capsulatum growth in nanomolar to low micromolar concentrations. These compounds also reduced the intracellular infection in an alveolar macrophage cell line. Overall, this lipid metabolic map revealed pathways that can be targeted for drug development.


  • Open Access

    Multi-omics Signature of Candida auris , an Emerging and Multidrug-Resistant Pathogen

    by Daniel Zamith-Miranda, Heino M. Heyman, Levi G. Cleare, Sneha P. Couvillion, Geremy C. Clair, Erin L. Bredeweg, Attila Gacser, Leonardo Nimrichter, Ernesto S. Nakayasu, Joshua D. Nosanchuk

    Candida auris was first described in Japan in 2009 and has now been the cause of significant outbreaks across the globe. The high number of isolates that are resistant to one or more antifungals, as well as the high mortality rates from patients with bloodstream infections, has attracted the attention of the medical mycology, infectious disease, and public health communities to this pathogenic fungus. In the current work, we performed a broad multi-omics approach on two clinical isolates isolated in New York, the most affected area in the United States and found that the omic profile of C. auris differs significantly from C. albicans . In addition to our insights into C. auris carbon utilization and lipid and protein content, we believe that the availability of these data will enhance our ability to combat this rapidly emerging pathogenic yeast.


  • Multimodal microchannel and nanowell-based microfluidic platforms for bioimaging

    by Tao Geng, Chuck R. Smallwood, Ying Zhu, Erin L. Bredeweg, Scott E. Baker, James E. Evans, Ryan T. Kelly

    Modern live-cell imaging approaches permit real-time visualization of biological processes. However, limitations for unicellular organism trapping, culturing and long-term imaging can preclude complete understanding of how such microorganisms respond to perturbations in their local environment or linking single-cell variability to whole population dynamics. We have developed microfluidic platforms to overcome prior technical bottlenecks to allow both chemostat and compartmentalized cellular growth conditions using the same device. Additionally, a nanowell-based platform enables a high throughput approach to scale up compartmentalized imaging optimized within the microfluidic device. These channel and nanowell platforms are complementary, and both provide fine control over the local environment as well as the ability to add/replace media components at any experimental time point.

  • Open Access

    Erratum to: A molecular genetic toolbox for Yarrowia lipolytica

    by Erin L. Bredeweg, Kyle R. Pomraning, Ziyu Dai, Jens Nielsen, Eduard J. Kerkhoven, Scott E. Baker

    [This corrects the article DOI: 10.1186/s13068-016-0687-7.].


  • Open Access

    Regulation of Nitrogen Metabolism by GATA Zinc Finger Transcription Factors in Yarrowia lipolytica

    by Kyle R. Pomraning, Erin L. Bredeweg, Scott E. Baker

    Fungi accumulate lipids in a manner dependent on the quantity and quality of the nitrogen source on which they are growing. In the oleaginous yeast Yarrowia lipolytica, growth on a complex source of nitrogen enables rapid growth and limited accumulation of neutral lipids, while growth on a simple nitrogen source promotes lipid accumulation in large lipid droplets. Here we examined the roles of nitrogen catabolite repression and its regulation by GATA zinc finger transcription factors on lipid metabolism in Y. lipolytica. Deletion of the GATA transcription factor genes gzf3 and gzf2 resulted in nitrogen source-specific growth defects and greater accumulation of lipids when the cells were growing on a simple nitrogen source. Deletion of gzf1, which is most similar to activators of genes repressed by nitrogen catabolite repression in filamentous ascomycetes, did not affect growth on the nitrogen sources tested. We examined gene expression of wild-type and GATA transcription factor mutants on simple and complex nitrogen sources and found that expression of enzymes involved in malate metabolism, beta-oxidation, and ammonia utilization are strongly upregulated on a simple nitrogen source. Deletion of gzf3 results in overexpression of genes with GATAA sites in their promoters, suggesting that it acts as a repressor, while gzf2 is required for expression of ammonia utilization genes but does not grossly affect the transcription level of genes predicted to be controlled by nitrogen catabolite repression. Both GATA transcription factor mutants exhibit decreased expression of genes controlled by carbon catabolite repression via the repressor mig1, including genes for beta-oxidation, highlighting the complex interplay between regulation of carbon, nitrogen, and lipid metabolism. IMPORTANCE Nitrogen source is commonly used to control lipid production in industrial fungi. Here we identified regulators of nitrogen catabolite repression in the oleaginous yeast Y. lipolytica to determine how the nitrogen source regulates lipid metabolism. We show that disruption of both activators and repressors of nitrogen catabolite repression leads to increased lipid accumulation via activation of carbon catabolite repression through an as yet uncharacterized method.


  • Open Access

    A molecular genetic toolbox for Yarrowia lipolytica

    by Erin L. Bredeweg, Kyle R. Pomraning, Ziyu Dai, Jens Nielsen, Eduard J. Kerkhoven, Scott E. Baker

    Yarrowia lipolytica is an ascomycete yeast used in biotechnological research for its abilities to secrete high concentrations of proteins and accumulate lipids. Genetic tools have been made in a variety of backgrounds with varying similarity to a comprehensively sequenced strain. We have developed a set of genetic and molecular tools in order to expand capabilities of Y. lipolytica for both biological research and industrial bioengineering applications. In this work, we generated a set of isogenic auxotrophic strains with decreased non-homologous end joining for targeted DNA incorporation. Genome sequencing, assembly, and annotation of this genetic background uncovers previously unidentified genes in Y. lipolytica. To complement these strains, we constructed plasmids with Y. lipolytica-optimized superfolder GFP for targeted overexpression and fluorescent tagging. We used these tools to build the “Yarrowia lipolytica Cell Atlas,” a collection of strains with endogenous fluorescently tagged organelles in the same genetic background, in order to define organelle morphology in live cells. These molecular and isogenetic tools are useful for live assessment of organelle-specific protein expression, and for localization of lipid biosynthetic enzymes or other proteins in Y. lipolytica. This work provides the Yarrowia community with tools for cell biology and metabolism research in Y. lipolytica for further development of biofuels and natural products.


  • Open Access

    TheNeurosporaTranscription Factor ADV-1 Transduces Light Signals and Temporal Information to Control Rhythmic Expression of Genes Involved in Cell Fusion

    by Rigzin Dekhang, Cheng Wu, Kristina M Smith, Teresa M Lamb, Matthew Peterson, Erin L Bredeweg, Oneida Ibarra, Jillian M Emerson, Nirmala Karunarathna, Anna Lyubetskaya, et al.

    Light and the circadian clock have a profound effect on the biology of organisms through the regulation of large sets of genes. Toward understanding how light and the circadian clock regulate gene expression, we used genome-wide approaches to identify the direct and indirect targets of the light-responsive and clock-controlled transcription factor ADV-1 in Neurospora crassa. A large proportion of ADV-1 targets were found to be light- and/or clock-controlled, and enriched for genes involved in development, metabolism, cell growth, and cell fusion. We show that ADV-1 is necessary for transducing light and/or temporal information to its immediate downstream targets, including controlling rhythms in genes critical to somatic cell fusion. However, while ADV-1 targets are altered in predictable ways in Δadv-1 cells in response to light, this is not always the case for rhythmic target gene expression. These data suggest that a complex regulatory network downstream of ADV-1 functions to generate distinct temporal dynamics of target gene expression relative to the central clock mechanism.